BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27145922)

  • 21. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.
    Shim JS; Kim HG; Ju MS; Choi JG; Jeong SY; Oh MS
    J Ethnopharmacol; 2009 Nov; 126(2):361-5. PubMed ID: 19703534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP(+)-elicited apoptosis.
    Cheng YF; Zhu GQ; Wang M; Cheng H; Zhou A; Wang N; Fang N; Wang XC; Xiao XQ; Chen ZW; Li QL
    Neurosci Res; 2009 Jan; 63(1):52-8. PubMed ID: 19022306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
    Dabbeni-Sala F; Di Santo S ; Franceschini D; Skaper SD; Giusti P
    FASEB J; 2001 Jan; 15(1):164-170. PubMed ID: 11149904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
    Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M
    Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The novel squamosamide derivative FLZ protects against 6-hydroxydopamine-induced apoptosis through inhibition of related signal transduction in SH-SY5Y cells.
    Zhang D; Zhang JJ; Liu GT
    Eur J Pharmacol; 2007 Apr; 561(1-3):1-6. PubMed ID: 17359966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
    Sharma SK; Ebadi M
    Antioxid Redox Signal; 2003 Jun; 5(3):251-64. PubMed ID: 12880480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
    O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
    Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fructose-2,6-diphosphate and glycolysis of tumor cells].
    Hue L
    Bull Mem Acad R Med Belg; 1989; 144(11):570-7; discussion 578-9. PubMed ID: 2561667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis.
    Chesney J
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):535-9. PubMed ID: 16912547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eucommia ulmoides Oliv. bark. attenuates 6-hydroxydopamine-induced neuronal cell death through inhibition of oxidative stress in SH-SY5Y cells.
    Kwon SH; Ma SX; Hong SI; Kim SY; Lee SY; Jang CG
    J Ethnopharmacol; 2014 Feb; 152(1):173-82. PubMed ID: 24440915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effects of luteolin against apoptosis induced by 6-hydroxydopamine on rat pheochromocytoma PC12 cells.
    Guo DJ; Li F; Yu PH; Chan SW
    Pharm Biol; 2013 Feb; 51(2):190-6. PubMed ID: 23035972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease.
    Zhu G; Wang X; Chen Y; Yang S; Cheng H; Wang N; Li Q
    Planta Med; 2010 Nov; 76(16):1820-6. PubMed ID: 20509103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meclizine inhibits mitochondrial respiration through direct targeting of cytosolic phosphoethanolamine metabolism.
    Gohil VM; Zhu L; Baker CD; Cracan V; Yaseen A; Jain M; Clish CB; Brookes PS; Bakovic M; Mootha VK
    J Biol Chem; 2013 Dec; 288(49):35387-95. PubMed ID: 24142790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective activity of guanosine in an in vitro model of Parkinson's disease.
    Giuliani P; Romano S; Ballerini P; Ciccarelli R; Petragnani N; Cicchitti S; Zuccarini M; Jiang S; Rathbone MP; Caciagli F; Di Iorio P
    Panminerva Med; 2012 Dec; 54(1 Suppl 4):43-51. PubMed ID: 23241934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-Ecdysterone Protects SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Apoptosis via Mitochondria-Dependent Mechanism: Involvement of p38(MAPK)-p53 Signaling Pathway.
    Pan Z; Niu Y; Liang Y; Zhang X; Dong M
    Neurotox Res; 2016 Oct; 30(3):453-66. PubMed ID: 27229883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells.
    Lin YC; Uang HW; Lin RJ; Chen IJ; Lo YC
    J Pharmacol Exp Ther; 2007 Dec; 323(3):877-87. PubMed ID: 17855475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
    Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
    Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes.
    Houddane A; Bultot L; Novellasdemunt L; Johanns M; Gueuning MA; Vertommen D; Coulie PG; Bartrons R; Hue L; Rider MH
    Cell Signal; 2017 Jun; 34():23-37. PubMed ID: 28235572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro.
    Bar-Am O; Amit T; Youdim MB
    J Neurochem; 2007 Oct; 103(2):500-8. PubMed ID: 17635668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
    Murray TK; Whalley K; Robinson CS; Ward MA; Hicks CA; Lodge D; Vandergriff JL; Baumbarger P; Siuda E; Gates M; Ogden AM; Skolnick P; Zimmerman DM; Nisenbaum ES; Bleakman D; O'Neill MJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):752-62. PubMed ID: 12730350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.